ask="6.2500"
ask_size="100"
average_daily_volume="36811"
bid="3.7000"
bid_size="1000"
book_value="0.0000"
change="+0.0574"
change_from_200_day_moving_average="-0.7176"
change_from_50_day_moving_average="0.3971"
change_from_52_week_high="-9.4126"
change_From_52_week_low="1.2374"
change_in_percent="+1.4987%"
close="3.8874"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-11.2650"
ebitda="0.00"
eps_estimate_current_year="-5.0600"
eps_estimate_next_quarter="-0.8400"
eps_estimate_next_year="-3.1800"
ex_dividend_date="N/A"
float_shares="N/A"
high="3.9000"
high_52_weeks="13.3000"
last_trade_date="1/13/2017"
last_trade_price="3.8874"
last_trade_size="200"
last_trade_time="3:39pm"
low="3.8000"
low_52_weeks="2.6500"
market_capitalization="N/A"
moving_average_200_day="4.6050"
moving_average_50_day="3.4903"
name="Caladrius Biosciences
Inc."
notes="N/A"
one_year_target_price="11.1700"
open="3.8900"
pe_ratio="N/A"
peg_ratio="-0.0100"
percent_change_from_200_day_moving_average="-15.5838%"
percent_change_from_50_day_moving_average="+11.3772%"
percent_change_from_52_week_high="-70.7714%"
percent_change_from_52_week_low="+46.6943%"
previous_close="3.8300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.0000"
stock_exchange="NCM"
symbol="CLBS"
volume="15181"
weeks_range_52="2.6500 - 13.3000"
